Find your path to Mark
1,663 people in our graph share verified history with Mark — schools, employers, funds. One of them is your warm intro.
Laura BuhlerunlockedMark: together at McKinsey & Company (2009–2010)
×9Mark: together at Goldman Sachs
Mark: together at McKinsey & Company
Mark: together at Henley Business School
About
Mark Beards is the interim CEO of Santero Therapeutics and the author of "Beards on Biotech." His career spans medtech and biotech start-ups, large pharma, and investment banking, with experience in capital raising, mergers and acquisitions, and global product launches. He has raised $40 million across seed and Series A funding rounds.
Chief Executive Officer at SANTERO
Intro paths
→
In turn, Mark can intro founders to SANTERO's investors below.
SANTERO's investors · 2
Co-founders at SANTERO
AG
Abel Garcia-PinoCo-founder & Scientific Advisor
CG
Cédric GovaertsCo-founder & Scientific Advisor
Experience
- Santero TherapeuticsInterim CEOcurrent2025 — present
- PFU TherapeuticsChairmancurrent2025 — present
- AMPLY DiscoveryChairmancurrent2023 — present
- Fountainhead Consulting LimitedOwnercurrent2018 — presentUnited Kingdom
- Mendel PartnersStrategic Advisorcurrent2021 — present
- MotionHallSenior Advisor, Biotechnology2021 — 2022
- Sutura TherapeuticsChief Executive Officer2019 — 2021United Kingdom
- UTILITY therapeuticsSenior Board Advisor2020 — 2021
- UTILITY therapeuticsChief Executive Officer2017 — 2020United Kingdom
- CelixirGroup Chief Financial Officer2017London, United Kingdom
- CelixirDirector of Corporate Development2015 — 2017London, United Kingdom
- CELL THERAPY LIMITEDExecutive Board Member2015 — 2017London, United Kingdom
- KPMGDirector, Healthcare and Life Sciences Strategy2013 — 2015London, United Kingdom
- Charles River AssociatesVice President, Co-lead European Life Sciences2012 — 2013London, United Kingdom
- Goldman SachsVice President, Head of Equity Research, Healthcare2010 — 2012
- McKinsey & CompanyEngagement Manager2007 — 2010
- GlaxoSmithKlineGlobal Strategy Manager2002 — 2007
- Abbott LaboratoriesInternational Business Development Manager2001 — 2002
Skills & more
Strategic Leadership5Merger & Acquisition Integration3Capital Raising2Biopharma CommercialisationFinancial AnalysisFinancial ModelingProject ManagementProject Management Office (PMO)Acquisition IntegrationFundraisingBiotechnology IndustryLicensing Strategy
+12 more
LicensingLicensing NegotiationsExecutive CoachingPharmaceutical IndustryStrategyPharmaceuticsR&DDrug DiscoveryProduct Lifecycle ManagementCommercializationCorporate DevelopmentCompetitive IntelligenceFrom Mark's professional profile.
Frequently asked questions
- Who is Mark Beards?
- Mark Beards is the interim CEO of Santero Therapeutics and the author of "Beards on Biotech." His career spans medtech and biotech start-ups, large pharma, and investment banking, with experience in capital raising, mergers and acquisitions, and global product launches. He has raised $40 million across seed and Series A funding rounds.
- Where does Mark Beards work?
- Mark Beards is Chief Executive Officer at SANTERO.
- Where did Mark Beards go to school?
- Mark Beards studied at The Chartered Institute of Management Accountants (ACMA, Accounting); Henley Business School (Diploma of Business Management, Business); University of Oxford (Master of Arts (M.A.), Mathematics).
Same school
Also attended The Chartered Institute of Management Accountants56
Shelley MargetsonManaging Partner at V-Bio VenturesBryan TurnerPartner at Spear CapitalLuke CurranSenior Analyst at Naples Technology VenturesNatalie EvansFinance Director at Calculus Capital Ltd.Hannah WilliamsonSenior Investment Manager at Edge VCTania HayesCOO, Strategic Equity at Gresham House Ventures
+ 50 more
Also attended Henley Business School95
John HortonInvestor at DN CapitalIrene ArdenstedtInvestor at Luminar VenturesCharles VasletSenior Partner, Chief Revenue Officer at Emerald Technology Ventures AgSanne van ErpInvestment manager at NoaberKieran MudryyPartner at 4BIO CapitalJames ChapmanEntrepreneur in Residence at Cambridge Innovation Capital
+ 89 more
Also attended University of Oxford1,763
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,757 more
Shared employers
Also worked at Celixir1
Also worked at Goldman Sachs2,000
Marc AndreessenCo-founder & General Partner at Andreessen HorowitzJosh KushnerFounder & CEO of Thrive CapitalFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeMatt HuangCo-founder and Managing Partner at ParadigmTarek MansourCo-founder & CEO of KalshiColin WebbFounder & CEO of Avatar Robotics
+ 1,994 more
Also worked at McKinsey & Company2,000
Ann Miura-KoCo-founding Partner at FloodgateJeremy LiewPartner at Lightspeed Venture PartnersMike SpeiserManaging Director at Sutter Hill VenturesJeremy LevinePartner at Bessemer Venture PartnersFabrice GrindaCo-founder & Managing Partner at FJ LabsJeppe RindomCo-founder & CEO of Pleo
+ 1,994 more
Also worked at GlaxoSmithKline279
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 273 more